Camilla Hansen Nejstgaard

1.1k total citations · 1 hit paper
24 papers, 403 citations indexed

About

Camilla Hansen Nejstgaard is a scholar working on Statistics, Probability and Uncertainty, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Camilla Hansen Nejstgaard has authored 24 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Statistics, Probability and Uncertainty, 10 papers in Pharmacology and 7 papers in Economics and Econometrics. Recurrent topics in Camilla Hansen Nejstgaard's work include Meta-analysis and systematic reviews (14 papers), Pharmaceutical industry and healthcare (10 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Camilla Hansen Nejstgaard is often cited by papers focused on Meta-analysis and systematic reviews (14 papers), Pharmaceutical industry and healthcare (10 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Camilla Hansen Nejstgaard collaborates with scholars based in Denmark, United Kingdom and France. Camilla Hansen Nejstgaard's co-authors include Asbjørn Hróbjartsson, Andreas Lundh, Isabelle Boutron, Lisa Bero, Theresa HM Moore, Anders W Jørgensen, Ella Flemyng, Kerry Dwan, Karsten Juhl Jørgensen and Julian P. T. Higgins and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Cochrane Database of Systematic Reviews.

In The Last Decade

Camilla Hansen Nejstgaard

21 papers receiving 397 citations

Hit Papers

Using Risk of Bias 2 to assess results from randomised co... 2023 2026 2024 2025 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane
    2023 104 citations Ella Flemyng, Theresa HM Moore et al. BMJ evidence-based medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camilla Hansen Nejstgaard Denmark 9 102 83 81 77 61 24 403
Craig Robbins United States 10 54 0.5× 27 0.3× 145 1.8× 92 1.2× 103 1.7× 12 403
Lauren A Ogden United States 11 224 2.2× 124 1.5× 351 4.3× 227 2.9× 130 2.1× 13 649
Ignacio Atal France 11 21 0.2× 205 2.5× 115 1.4× 154 2.0× 57 0.9× 20 516
Moher United Kingdom 3 42 0.4× 150 1.8× 90 1.1× 75 1.0× 68 1.1× 3 439
Lukas G. Keil United States 9 49 0.5× 256 3.1× 190 2.3× 141 1.8× 67 1.1× 15 533
Dileep Kumar Rohra Pakistan 12 50 0.5× 16 0.2× 122 1.5× 60 0.8× 39 0.6× 39 418
Natalie McGauran Germany 15 129 1.3× 235 2.8× 257 3.2× 319 4.1× 114 1.9× 24 937
Helen J Curtis United Kingdom 15 27 0.3× 64 0.8× 216 2.7× 120 1.6× 150 2.5× 40 919
Laragh Gollogly Belgium 11 14 0.1× 26 0.3× 72 0.9× 34 0.4× 56 0.9× 23 385
Hae Hiang Song South Korea 9 26 0.3× 91 1.1× 43 0.5× 12 0.2× 37 0.6× 13 372

Countries citing papers authored by Camilla Hansen Nejstgaard

Since Specialization
Citations

This map shows the geographic impact of Camilla Hansen Nejstgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Hansen Nejstgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Hansen Nejstgaard more than expected).

Fields of papers citing papers by Camilla Hansen Nejstgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Hansen Nejstgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Hansen Nejstgaard. The network helps show where Camilla Hansen Nejstgaard may publish in the future.

Co-authorship network of co-authors of Camilla Hansen Nejstgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Hansen Nejstgaard. A scholar is included among the top collaborators of Camilla Hansen Nejstgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Hansen Nejstgaard. Camilla Hansen Nejstgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nejstgaard, Camilla Hansen, et al.. (2025). Conflict of interest policies for editors and peer reviewers in medical journals: cross-sectional study. Journal of Clinical Epidemiology. 188. 111980–111980.
2.
Nejstgaard, Camilla Hansen, et al.. (2025). Peer reviewers’ conflicts of interest in biomedical research: scoping review. BMJ evidence-based medicine. 30(2). 104–117. 3 indexed citations
3.
Nejstgaard, Camilla Hansen, An‐Wen Chan, Kerry Dwan, et al.. (2025). A scoping review identifies comments suggesting modifications to PRISMA-P 2015. Journal of Clinical Epidemiology. 182. 111760–111760. 2 indexed citations
4.
Laursen, David Ruben Teindl, Stig Brorson, Andreas Lundh, et al.. (2024). Critical reading of systematic review articles. Ugeskrift for Læger. 186(13). 1–11. 1 indexed citations
5.
Nejstgaard, Camilla Hansen, An‐Wen Chan, Kerry Dwan, et al.. (2024). A scoping review identifies comments suggesting modifications to PRISMA-P 2015. OSF Preprints (OSF Preprints).
6.
Østengaard, Lasse, Isabelle Boutron, An‐Wen Chan, et al.. (2024). Development of a topic‐specific bibliographic database supporting the updates of SPIRIT 2013 and CONSORT 2010. SHILAP Revista de lepidopterología. 2(5). e12057–e12057.
7.
Tunn, R., Isabelle Boutron, An‐Wen Chan, et al.. (2024). Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements. Journal of Clinical Epidemiology. 169. 111309–111309. 6 indexed citations
8.
Nejstgaard, Camilla Hansen, Isabelle Boutron, An‐Wen Chan, et al.. (2023). A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010. Journal of Clinical Epidemiology. 155. 48–63. 5 indexed citations
9.
Flemyng, Ella, Theresa HM Moore, Isabelle Boutron, et al.. (2023). Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane. BMJ evidence-based medicine. 28(4). 260–266. 104 indexed citations breakdown →
10.
Laursen, David Ruben Teindl, Camilla Hansen Nejstgaard, Espen Bjørkedal, et al.. (2023). Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo. Cochrane Database of Systematic Reviews. 2023(3). MR000055–MR000055. 8 indexed citations
11.
Hopewell, Sally, Isabelle Boutron, An‐Wen Chan, et al.. (2022). An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials. Nature Medicine. 28(9). 1740–1743. 53 indexed citations
12.
Hróbjartsson, Asbjørn, et al.. (2022). Adherence to the PRISMA-P 2015 reporting guideline was inadequate in systematic review protocols. Journal of Clinical Epidemiology. 150. 179–187. 17 indexed citations
13.
Fabbri, Alice, Camilla Hansen Nejstgaard, Quinn Grundy, et al.. (2021). Association Between Conflicts of Interest and Authors’ Positions on Harms of Varenicline: a Cross-Sectional Analysis. Journal of General Internal Medicine. 37(2). 290–297. 3 indexed citations
14.
Nejstgaard, Camilla Hansen, Andreas Lundh, Gemma Clayton, et al.. (2021). Combining meta‐epidemiological study datasets on commercial funding of randomised clinical trials: Database, methods, and descriptive results of the COMFIT study. Research Synthesis Methods. 13(2). 214–228. 1 indexed citations
15.
Nejstgaard, Camilla Hansen, Lisa Bero, Asbjørn Hróbjartsson, et al.. (2020). Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ. 371. m4234–m4234. 71 indexed citations
16.
Nejstgaard, Camilla Hansen, Lisa Bero, Asbjørn Hróbjartsson, et al.. (2020). Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. Cochrane Database of Systematic Reviews. 2020(12). MR000040–MR000040. 27 indexed citations
17.
Nejstgaard, Camilla Hansen, Lisa Bero, Asbjørn Hróbjartsson, et al.. (2019). Conflicts of interest and recommendations in clinical guidelines, opinion pieces, and narrative reviews. Cochrane Database of Systematic Reviews. 7 indexed citations
18.
Nejstgaard, Camilla Hansen, Andreas Lundh, Kristine Rasmussen, & Asbjørn Hróbjartsson. (2019). Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality. Cochrane Database of Systematic Reviews. 2019(8). MR000047–MR000047. 50 indexed citations
19.
Nejstgaard, Camilla Hansen, et al.. (2017). Co-payments for general practitioners in Denmark: an analysis using two policy models. BMC Health Services Research. 17(1). 9–9. 4 indexed citations
20.
Nejstgaard, Camilla Hansen, Andreas Lundh, Kristine Rasmussen, Peter C Gøtzsche, & Asbjørn Hróbjartsson. (2017). Financial conflicts of interest and outcomes and quality of systematic reviews. Cochrane Database of Systematic Reviews. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Robbins Breakdown of academic impact, for papers by Lauren A Ogden Breakdown of academic impact, for papers by Ignacio Atal Breakdown of academic impact, for papers by Moher Breakdown of academic impact, for papers by Lukas G. Keil Breakdown of academic impact, for papers by Dileep Kumar Rohra Breakdown of academic impact, for papers by Natalie McGauran Breakdown of academic impact, for papers by Helen J Curtis Breakdown of academic impact, for papers by Laragh Gollogly Breakdown of academic impact, for papers by Hae Hiang Song
Rankless by CCL
2026